THIRD AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • April 11th, 2022 • Ocean Biomedical, Inc. • Pharmaceutical preparations
Contract Type FiledApril 11th, 2022 Company IndustryThis Third Amendment to Exclusive License Agreement (this “Amendment”) is entered into as of March 25, 2022 (the “Amendment Date”), by and between Elkurt, Inc., a Rhode Island corporation with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc., a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).
THIRD AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • April 11th, 2022 • Ocean Biomedical, Inc. • Pharmaceutical preparations
Contract Type FiledApril 11th, 2022 Company IndustryThis Third Amendment to Exclusive License Agreement (this “Amendment”) is entered into as of March 25, 2022 (the “Amendment Date”), by and between Elkurt, Inc., a Rhode Island corporation with an address at 297 President Ave, Providence RI 02906 (“Elkurt”) and Ocean Biomedical Inc., a Delaware corporation with an address at 19W060 Avenue LaTours, Oak Brook, IL 60523 (“Licensee”).